Who
Bryan T. Vaughn
EVP and President, Diagnostics
Company insider
Files Form 4 as: EVP and President, Diagnostics, Labcorp Holdings.
In numbers
- Trades disclosed
- 36
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $134K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 6 Feb 2026
- Last trade
- 1 Sep 2026
- Last filed
- 3 Sep 2026
Companies traded
Activity over time
1 Jun – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Sep 2026filed 3 Sep 2026 | LH Labcorp Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —1,500 at $0.00 | filing |
| 1 Sep 2026filed 3 Sep 2026 | LH Labcorp Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —1,500 at $0.00 | filing |
| 2 Jul 2026filed 6 Jul 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $67K234 at $286.19 | filing |
| 2 Jul 2026filed 6 Jul 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $67K234 at $286.19 | filing |
| 1 Jul 2026filed 6 Jul 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —327 | filing |
| 1 Jul 2026filed 6 Jul 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $26K93 at $283.88 | filing |
| 1 Jul 2026filed 6 Jul 2026 | LH Labcorp Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —327 at $0.00 | filing |
| 1 Jul 2026filed 6 Jul 2026 | LH Labcorp Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —327 at $0.00 | filing |
| 1 Jul 2026filed 6 Jul 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —327 | filing |
| 1 Jul 2026filed 6 Jul 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $26K93 at $283.88 | filing |
| 26 Mar 2026filed 30 Mar 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —1,584 at $0.00 | filing |
| 26 Mar 2026filed 30 Mar 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $121K451 at $268.38 | filing |
| 26 Mar 2026filed 30 Mar 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —1,584 at $0.00 | filing |
| 26 Mar 2026filed 30 Mar 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $121K451 at $268.38 | filing |
| 11 Feb 2026filed 13 Feb 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —323 | filing |
| 11 Feb 2026filed 13 Feb 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $27K93 at $289.89 | filing |
| 11 Feb 2026filed 13 Feb 2026 | LH Labcorp Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —323 at $0.00 | filing |
| 11 Feb 2026filed 13 Feb 2026 | LH Labcorp Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —323 at $0.00 | filing |
| 11 Feb 2026filed 13 Feb 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —323 | filing |
| 11 Feb 2026filed 13 Feb 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $27K93 at $289.89 | filing |
News
Labcorp Holdings Inc. (NYSE:LH) Shares to Pay Quarterly Dividend of $0.72LH · dailypolitical.com · 21 Oct 2026Labcorp To Buy Myriad Genetics' Prenatal Testing Business For $210 MlnLH · finanzen.ch · 20 Oct 2026Labcorp To Acquire BioReference Health Assets; OPKO Shares Rise 7.35%LH · rttnews.com · 15 Oct 2026
0 headlines in the last 90 days name Bryan T. Vaughn; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.